Screening

Implementing Universal Screening to Identify Suicide Risk in Pediatric Patients

Retrieved on: 
Tuesday, July 27, 2021
Health, Medicine, Suicide, Screening, Emergency department, Patient safety

A new study in the August 2021 issue of The Joint Commission Journal on Quality and Patient Safety (JQPS), Implementing Universal Suicide Risk Screening in a Pediatric Hospital , details the development and implementation of a hospital-wide program to identify teens at elevated risk for suicide and to connect them with services.

Key Points: 
  • A new study in the August 2021 issue of The Joint Commission Journal on Quality and Patient Safety (JQPS), Implementing Universal Suicide Risk Screening in a Pediatric Hospital , details the development and implementation of a hospital-wide program to identify teens at elevated risk for suicide and to connect them with services.
  • Patients 12 years and older were screened for suicide risk using the Ask Suicide-Screening Questions (ASQ) at Childrens Mercy Kansas City, which includes two emergency departments, three urgent care clinics, and a number of ambulatory clinics.
  • During the first year of screening, 138,598 screens were completed, and 6.8% of screens were positive for elevated suicide risk.
  • Social workers also completed outreach to patients in the weeks following a positive screen.

Antibe Therapeutics Provides July 2021 Corporate Update

Retrieved on: 
Tuesday, July 27, 2021
Biotechnology, Pharmaceutical, Health, Clinical trials, Antibe Therapeutics, Forward-looking statement, Medicine, Screening, Articles, Health sciences

Antibe is taking a comprehensive approach to maximizing the likelihood of a successful Phase III program outcome.

Key Points: 
  • Antibe is taking a comprehensive approach to maximizing the likelihood of a successful Phase III program outcome.
  • The program also combines several state-of-the-art aspects, including the hiring of leading providers of bioanalytic, quality control and data management services.
  • The latter will enable us to track and manage screening and enrollment in real-time, ensuring that the subject population matches trial criteria.
  • Antibe Therapeutics assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those reflected in the forward-looking statements except as required by applicable law.

Phreesia Partners with Safe Environment for Every Kid (SEEK) to Automate Delivery of its Screening Tool

Retrieved on: 
Thursday, July 22, 2021
Health, Consumer, Environment, Parenting, Children, General Health, Articles, Health, Human development, Determinants of health, Public health, Developmental psychology, Adverse childhood experiences, Child development, Initiatives, Screening, Primary care

Phreesia is pleased to partner with the developers of the Safe Environment for Every Kid (SEEK) model to deliver their screening tool for adverse childhood experiences (ACEs) and negative social determinants of health (SDOH) to pediatric primary care providers across Phreesias network.

Key Points: 
  • Phreesia is pleased to partner with the developers of the Safe Environment for Every Kid (SEEK) model to deliver their screening tool for adverse childhood experiences (ACEs) and negative social determinants of health (SDOH) to pediatric primary care providers across Phreesias network.
  • This automated questionnaire will enhance pediatricians ability to provide high-quality, comprehensive care to their patients, and to promote the well-being of the children and families they serve.
  • Phreesia greatly helps to implement SEEK, making it easy for parents and professionals to use the tool, and ultimately supporting better outcomes for children and families.
  • Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process.

Cureduchenne Launches Innovative Supplemental Newborn Screening Initiative Offering Opportunity for Early Diagnosis of Rare, Fatal Disease

Retrieved on: 
Thursday, July 22, 2021
Medicine, Neonatology, Health sciences, Epidemiology, Newborn screening, Screening, Clinical medicine

The partnership between CureDuchenne and Brigham and Women's Hospital is the first program to offer supplemental newborn screening for Duchenne in a clinical setting.

Key Points: 
  • The partnership between CureDuchenne and Brigham and Women's Hospital is the first program to offer supplemental newborn screening for Duchenne in a clinical setting.
  • Early diagnosis provides families the opportunity to take advantage of therapeutic interventions that could improve outcomes.
  • "Identifying an affected child early could help us provide critical, early therapy to help preserve their muscle function."
  • "Diagnostic odysseys for Duchenne would be avoided and therapy could be initiated early for these children," said Parad.

Catalyst Biosciences Announces First Patient Screened for CFI deficiency in its CB 4332 Screening and Natural History of Disease Studies

Retrieved on: 
Thursday, July 22, 2021
Branches of biology, Medicine, Clinical medicine, Biomarkers, Cell biology, Screening

"The findings from the CFI deficiency screening and natural history of disease studies will be instrumental in identifying patients for the Phase 1/2 trial of CB 4332, planned for mid-year 2022, said Nassim Usman, Ph.D., president and chief executive officer of Catalyst.

Key Points: 
  • "The findings from the CFI deficiency screening and natural history of disease studies will be instrumental in identifying patients for the Phase 1/2 trial of CB 4332, planned for mid-year 2022, said Nassim Usman, Ph.D., president and chief executive officer of Catalyst.
  • Following the disease manifestations and biomarkers of this complement disorder will be important in unlocking the full therapeutic potential of CB 4332.
  • The ConFIrm screening study will measure CFI levels and activity in patients who have diseases related to a CFI deficiency and who may potentially benefit from CB 4332 treatment.
  • The findings from these studies will identify opportunities to potentially develop CB 4332 for treatment in multiple indications.

Myriad Genetics Supports New ACMG Recommendation Statement on Increasing Access to Carrier Screening for All Ethnicities

Retrieved on: 
Wednesday, July 21, 2021
Medicine, Branches of biology, Medical genetics, Medical tests, ACMG, Health care, Myriad Genetics, Screening, American College of Medical Genetics and Genomics

ACMG previously recommended more limited carrier screening and for only certain ethnicities.

Key Points: 
  • ACMG previously recommended more limited carrier screening and for only certain ethnicities.
  • Additionally, ACMG recommends that insurers cover the costs of such tests, which will improve equitable patient access.
  • Myriad Genetics has been a leader in establishing the evidence base for carrier screening and for developing inclusive products that serve patients of all ancestries.
  • We applaud ACMG for its new, and more inclusive statement, recommending carrier screening to patients of all ethnicities for a broad panel of conditions, said Nicole Lambert, president of Myriad Genetic Laboratories.

Matrix Clinical Care Expands In-Home Services with New Testing and Diagnostic Capabilities

Retrieved on: 
Tuesday, July 20, 2021
Diabetes, Health, Medicine, Blindness, Diabetic retinopathy, Clinician, Retinopathy, Screening

SCOTTSDALE, Ariz., July 20, 2021 /PRNewswire/ --Matrix Clinical Care, a Matrix Medical Network (Matrix) company, today announced an expanded set of in-home testing and diagnostic capabilities to meet increasing demand for in-home healthcare.

Key Points: 
  • SCOTTSDALE, Ariz., July 20, 2021 /PRNewswire/ --Matrix Clinical Care, a Matrix Medical Network (Matrix) company, today announced an expanded set of in-home testing and diagnostic capabilities to meet increasing demand for in-home healthcare.
  • Matrix will partner with payors to extend the diagnostic screening capabilities available to their members, allowing Matrix clinicians to provide better real-time education and care to patients.
  • Equipping Matrix clinicians with new testing and diagnostic capabilities like Lead testing for pediatric patients and Diabetic Retinopathy Exams will allow them to provide better education and patient care.
  • We then provide care based on short- and long-term needs to make an immediate difference in the patient's quality of life," said Matrix Clinical Care Clinician Kelly Skovira, DNP.

Prenatal Testing & Newborn Screening Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 16, 2021
General Health, Women, Consumer, Health, Genetics, Medicine, Clinical medicine, Branches of biology, Medical tests, Midwifery, Prenatal testing, Newborn screening, Down syndrome, Screening, Predictive medicine, Elective genetic and genomic testing

The "Prenatal Testing & Newborn Screening Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Prenatal Testing & Newborn Screening Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The prenatal testing and newborn screening tests market consists of sales of prenatal testing and newborn screening tests services and related goods by entities (organizations, sole traders and partnerships) that provide prenatal testing and newborn screening tests, which help to determine various genetic and chromosomal diseases, to provide timely medical or surgical treatment of a condition before or after birth.
  • The use of machine learning and artificial intelligence is gradually gaining popularity in the prenatal testing and newborn screening market.
  • The prenatal testing and newborn screening market covered in this report is segmented by diagnostic type into non-invasive; invasive.

Determine dyslexia even at a distance with the FAR Screening Form Remote!

Retrieved on: 
Thursday, July 15, 2021
Articles, Education, Reading, Special education, Learning, Educational psychology, Learning to read, Dyslexia, Writing, Screening, Dyslexia research

Identify children at risk for dyslexia even at a distance with the FAR Screening Form Remote!

Key Points: 
  • Identify children at risk for dyslexia even at a distance with the FAR Screening Form Remote!
  • The FAR Screening Form Remote quickly identifies children at risk for developmental dyslexia.
  • Beyond pandemic needs, the FAR Screening Form Remote provides the ability to use this trusted dyslexia screening instrument in a variety of circumstances where face-to-face assessment is not possible.
  • The FAR Screening Form Remote can be administered to individuals from prekindergarten through college and offers grade-based normative data.

Cisive Announces ContractorDirect Solution to Help Businesses Streamline Contractor Screening

Retrieved on: 
Thursday, July 15, 2021
Articles, Medical terminology, Prevention, Screening, Temporary work, Workflow, Academic disciplines

HOLTSVILLE, N.Y., July 15, 2021 /PRNewswire-PRWeb/ -- Cisive, a global provider of compliance-driven human capital management and risk management solutions, announces the release of its new ContractorDirect background screening product, developed to assist businesses with streamlining the contingent labor screening process through an automated, self-initiated workflow.

Key Points: 
  • HOLTSVILLE, N.Y., July 15, 2021 /PRNewswire-PRWeb/ -- Cisive, a global provider of compliance-driven human capital management and risk management solutions, announces the release of its new ContractorDirect background screening product, developed to assist businesses with streamlining the contingent labor screening process through an automated, self-initiated workflow.
  • "We have developed a complete, innovative background screening solution that helps our clients maximize efficiencies in their contractor screening processes with our novel approach," said Michelle Smith, Director, Solution Management at Cisive.
  • Cisive's consumer-centered design makes this solution a win for everyone involved in the screening process, foremost the contractors themselves."
  • ContractorDirect is Cisive's full service screening product that offers businesses a compliant, intuitive, efficient, and user-friendly solution to completing the screening process for contractors, contingent labor, and gig workers.